Advertisement

Discovery of the First Stimulating Factors of Blood Vessels

  • Andreas Bikfalvi
Chapter

Abstract

The work of Judah Folkman indicated that one or more factors produced by a tumor could stimulate angiogenesis. These factors were called tumor angiogenesis factors (TAFs), and various laboratories set out to identify these TAFs. The problem was that even if the culture medium or the extracts of the tumor cells or of other tissues showed an important stimulatory activity for endothelial cells, the responsible factors could not be efficiently purified. This changed with the discovery that these factors had a strong affinity for heparin. Using heparin-sepharose chromatography, Michael Klagsbrun and Jay Shin from the Judah Folkman laboratory, and researchers from several other laboratories, were able to isolate these factors—which were called heparin-binding growth factors—and to determine their amino acid sequences [114–116] (Fig. 6.1).

References

  1. 114.
    Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M (1984) Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223(4642):1296–1299CrossRefPubMedGoogle Scholar
  2. 115.
    Klagsbrun M, Sullivan R, Smith S, Rybka R, Shing YE (1987) Purification of endothelial cell growth factors by heparin affinity chromatography. Methods Enzymol 147:95–105CrossRefPubMedGoogle Scholar
  3. 116.
    Lobb R, Sasse J, Sullivan R, Shing Y, D’Amore P, Jacobs J, Klagsbrun M (1986) Purification and characterization of heparin-binding endothelial cell growth factors. J Biol Chem 261(4):1924–1928PubMedGoogle Scholar
  4. 121.
    Klagsbrun M, Shing Y (1985) Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors. Proc Natl Acad Sci U S A 82(3):805–809CrossRefPubMedPubMedCentralGoogle Scholar
  5. 117.
    Schreiber AB, Kenney J, Kowalski J, Thomas KA, Gimenez-Gallego G, Rios-Candelore M, Di Salvo J, Barritault D, Courty J, Courtois Y, Moenner M, Loret C, Burgess WH, Mehlman T, Friesel R, Johnson W, Maciag T (1985) A unique family of endothelial cell polypeptide mitogens: the antigenic and receptor cross-reactivity of bovine endothelial cell growth factor, brain-derived acidic fibroblast growth factor, and eye-derived growth factor-II. J Cell Biol 101(4):1623–1626CrossRefPubMedGoogle Scholar
  6. 118.
    Risau W (1996) What, if anything, is an angiogenic factor? Cancer Metastasis Rev 15(2):149–151CrossRefPubMedGoogle Scholar
  7. 119.
    Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24(20):5480–5486CrossRefPubMedGoogle Scholar
  8. 120.
    Strydom DJ, Fett JW, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL (1985) Amino acid sequence of human tumor derived angiogenin. Biochemistry 24(20):5486–5494CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2017

Authors and Affiliations

  • Andreas Bikfalvi
    • 1
  1. 1.Angiogenesis and Tumor Microenvironment LaboratoryUniversity of Bordeaux and National Institute of Health and Medical ResearchPessacFrance

Personalised recommendations